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Background:  In developing  countries,  equipment  necessary  for diagnosis  is  only  available  in  few  central
laboratories,  which  are  less  accessible  and  of limited  capacity  to test  large  numbers  of incoming  samples.
Moreover,  the  transport  conditions  of  samples  are inadequate,  therefore  leading  to unreliable  results.
Objectives:  The  development  of a rapid,  inexpensive,  and  simple  test  would  allow  mobile  detection  of
viruses.
Study  design:  A  suitcase  laboratory  “Diagnostics-in-a-Suitcase”  (56 cm  × 45.5 cm  × 26.5 cm)  containing  all
reagents  and devices  necessary  for  performing  a reverse  transcription  recombinase  polymerase  ampli-
ﬁcation  (RT-RPA)  assay  was  developed.  As an  example,  two  RT-RPA  assays  were  established  for  the
detection  of  hemagglutinin  (H)  and  neuraminidase  (N)  genes  of  the novel  avian  inﬂuenza  (H7N9)  virus.
Results:  The  sensitivities  of  the  H7  and  the N9 RT-RPA  assays  were  10 and  100  RNA  molecules,  respectively.
The  assays  were  performed  at a single  temperature  (42 ◦C). The  results  were  obtained  within  2–7 min.
The  H7N9  RT-RPA  assays  did not  show  a cross-detection  either  of  any  other  respiratory  viruses  affecting
humans  and/or  birds  or of  the  human  or chicken  genomes.  All reagents  were  used,  stored,  and  transported
at ambient  temperature,  that  is, cold  chain  independent.  In  addition,  the  Diagnostics-in-a-Suitcase  was
operated  by a solar-powered  battery.
Conclusions:  The  developed  assay  protocol  and mobile  setup  performed  well.  Moreover,  it can be easily
implemented  to  perform  diagnoses  at airports,  quarantine  stations,  or farms  for rapid  on-site  viral  nucleic
acid detection.
© 2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Background
Reliable rapid diagnostic tools can generally help conﬁrm infec-
ion in suspected cases during disease outbreaks, and therefore
hey can help improve hygiene management and prevent the fur-
her spread of the disease. The most extensively used tools are
apid antigen detection tests (RDTs) [1,2]. RDTs are simple, fast
10–15 min), and suitable for point-of-care screening. Neverthe-
ess, many reports stress the limited sensitivity and speciﬁcity of
DTs [2–5], and RDT results are yet to be conﬁrmed by real-time
olymerase chain reaction (PCR).
∗ Corresponding author. Present address: Unit of Infection models, German Pri-
ate Center, Kellnerweg 4, 37077 Goettingen, Germany. Tel.: +49 551 3851295;
ax: +49 551 3851 266.
E-mail address: abdelwahed@dpz.eu (A. Abd El Wahed).
ttp://dx.doi.org/10.1016/j.jcv.2015.05.004
386-6532/© 2015 The Authors. Published by Elsevier B.V. This is an open access article u
d/4.0/).Currently, real-time PCR is the standard of molecular diagno-
sis [6–8]. Samples are sent to regional or central laboratories for
testing. Alternatively, a mobile real-time PCR system can be used
at an outbreak site for the detection of pathogen nucleic acid.
However, mobile real-time PCR devices are large, expensive, and
complex. In addition, the test run time varies between 50 and
90 min  [9].
For rapid wide-scale testing, robust easy-to-use molecular test
systems that can be applied in the ﬁeld provide a big advantage, as
they allow rapid on-site nucleic acid detection at the point of need.
Smart mobile assays should be able to discover silent or clinical
relevant cases even in rural areas with low infrastructure.
Recombinase polymerase ampliﬁcation (RPA) [10] represents an
alternative technology to the real-time PCR. RPA is an isothermal
DNA ampliﬁcation and detection technology. This assay is rapid
(2–15 min) and operated via a compact portable device (i.e., a tube
scanner, 19 cm × 17.5 cm)  [11–14].
nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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Fig. 1. Diagnostics-in-a-Suitcase. It contains all equipment and reagents for per-
forming the RT-RPA assay.A. Abd El Wahed et al. / Journal
. Objectives
In this study, reverse transcription RPA (RT-RPA) assays were
eveloped for the detection of avian inﬂuenza A (H7N9) virus.
oreover, “Diagnostics-in-a-Suitcase” (DiaS) was established in
rder to facilitate its use at the site of an outbreak.
. Study design
.1. Viral nucleic acid and oligonucleotides
The Quality Control for Molecular Diagnostics, Glasgow, Scot-
and, UK; the Landesgesundheitsamt Niedersachsen, Hanover,
ermany; and Robert Koch Institute, Berlin, Germany, provided the
uman viruses and viral nucleic acids (Table 1) used in this study.
he avian respiratory viral nucleic acid panel (Table 1) was  pro-
ided by the Friedrich-Loefﬂer-Institute, Greifswald-Insel Riems,
ermany.
Two RT-RPA assays were developed. As no program or strict
ules for designing RPA primers and probe were available, three
orward primers (FPs), three reverse primers (RPs), and one
xo-probes (exo-Ps) were tested for each assay to select the com-
ination producing the highest RT-RPA assay analytical sensitivity
Table 2). Oligonucleotides were synthesized by TIB MOLBIOL
Berlin, Germany).
.2. Diagnostics-in-a-SuitcaseTo simplify the use of H7N9 RT-RPA assays at the site of an
utbreak, DiaS (Fig. 1) was created. DiaS contains all reagents
nd equipment necessary for performing H7N9 RT-RPA assays. A
able 1
ist of viral nucleic acids. H7N9 RT-RPA assays detected only H7 and N9 RNA but not
ther nucleic acids of viruses causing respiratory manifestations.
Viral nucleic acid H7 RT-RPA
assay
N9 RT-RPA
assay
Human respiratory viruses
Coronavirus 229E, NL63, and OC43 − −
SARS coronavirus − −
MERS coronavirus − −
Inﬂuenza A (H1N1 pdm09) − −
Inﬂuenza A (H3N2) − −
Inﬂuenza A (H5N1) − −
Inﬂuenza A (H1N1 H275Y) − −
Inﬂuenza B (Victoria) − −
Inﬂuenza B (Yamagata) − −
Parainﬂuenza virus 1–4 (patient isolate)* − −
Respiratory syncytial virus A and B − −
Human rhinovirus A 16 − −
Human rhinovirus A 90 − −
Human rhinovirus A 8 − −
Human rhinovirus B 5 − −
Human rhinovirus B 42 − −
Human rhinovirus C − −
Enterovirus 68 − −
Human metapneumovirus A1 and B2 − −
Adenovirus type 1, 4, and 34 − −
Avian respiratory viruses
A/Anhui/1/13 (H7N9) + +
A/Chicken/Germany/79 “Taucha” (H7N7) + −
A/Chicken/Brescia/19/02 (H7N7) + −
A/Chicken/Germany/R28/03 (H7N7) + −
A/Cygnus olor/Germany/R1377/07 (H5N1) − −
A/Chicken/Egypt/0833-NLQP/2008 (H5N1) − −
A/Chicken/Vietnam/P78/05 (H5N1) − −
Newcastle disease virus clone 30 − −
Infectious laryngotracheitis virus U76 − −
Infectious laryngotracheitis virus (A489) − −
Infectious bronchitis M41 − −Fig. 2. Layout of the PVC layer of the Diagnostics-in-a-Suitcase. All measurements
are  in centimeters. The inside of the bold line represents the cutouts whereas the
dotted lines represent the distance between two  points.
case of size 56 cm × 45.5 cm × 26.5 cm (ZARGES GmbH, Weilheim,
Germany) is lined with foam at its base to act as a shock absorber
during transport. A PVC layer is attached to the foam, into which
indents are cut and sealed to render them watertight (Fig. 2).
These indents house the equipment needed to perform the sam-
ple processing and ampliﬁcation reactions: a tube scanner (Twista,
TwistDx, Cambridge, UK), disinfectant wipes (Pursept®-A Xpress,
Merz Consumer Hygiene GmbH, Luetjenburg, Germany), a waste
container (Sarstedt, Nuembrecht, Germany), a vortex (lab-Dancer,
IKA®, Staufen, Germany), a Sprout® Minicentrifuge (OMNILAB, Bre-
men, Germany), and two  easily reﬁllable Pipette Tip boxes (BRAND,
Wertheim, Germany), in addition to a micro-tube rack, scissors,
and a magnetic stand (Beckman Coulter, Krefeld, Germany). The
lid of the case contains a box for gloves, an FFP3 mask, protection
18 A. Abd El Wahed et al. / Journal of Clinical Virology 69 (2015) 16–21
Table  2
Sequence of primers and exo-probes for H7N9 RT-RPA assays.
Name Sequence 5′–3′ Amplicon size (nt)
H7-RPA-FP CACAGCAAATACAGGGAAGAGGCAATGCAAAATAG
121H7-RPA-RP GAAGTATGAAACATGATGCCCCGAAGCT
H7-RPA-P CAAAGTATCACATCTT (BHQ1-dT)(THF)(FAM-dT)AGCCGCTGCTTAGTTTGACTGGGTCAATCTG-PH
N9-RPA-FP CAGAGGGAAACACTCAAACGGAACAATACAC
129N9-RPA-RP CTAGTACTTGACCACCCAATGCATTCCACCCTGC
N9-RPA-P CTGCTGTTGTACAC(BHQ1-dT)(THF)(FAM-dT)GGGCGGTGATGATAGTGGCCAGCTTATCAG-PH
H PA as
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c7-RPA-FP and H7-RPA-RP are forward and reverse RPA primers for the H7 RT-R
T-RPA assay; H7-RPA-P and N9-RPA-P are exo-probes; BHQ1-dT, thymidine nucle
ucleotide-carrying ﬂuorophore; nt, nucleotides.
oggles, 1–10- and 10–100-l automatic micropipettes (Eppendorf
G, Hamburg, Germany), marker and boxes for storage buffers, and
PA kits. A solar panel and a power pack (Yeti 150 set, GOALZERO,
outh Bluffdale, UT, USA) provide the energy needed.
ig. 3. Analytical sensitivity of H7N9 RT-RPA assays. (A) The H7 and (B) the N9 RT-RPA a
07–101 RNA molecules/l of the H7 and N9 RNA molecular standards (graph generated 
olecules for the H7 (A) and the N9 (B) RT-RPA assays, respectively. The reverse transcr
erformed after 3 min  (no ﬂuorescence signal was  detected). 107 represented by black line
ontrol, orange. (For interpretation of the references to color in this text, the reader is refsay; N9-RPA-FP and N9-RPA-RP are forward and reverse RPA primers for the N9
carrying Black Hole Quencher-1; THF, tetrahydrofuran spacer; FAM-dT, thymidine
3.3. Workﬂow in the DiaSThe workﬂow consisted of total viral nucleic acid extrac-
tion using magnetic beads (Dynabeads® SILANE viral NA, Life
ssays. Fluorescence development via real-time detection using a dilution range of
by ESEquant tube scanner studio software). The sensitivities were 10 and 100 RNA
iption took place in the ﬁrst minute. To increase the sensitivity, a mixing step was
; 106, gray; 105, red; 104, blue; 103, green; 102, cyan; 101, dark khaki; and negative
erred to the web version of the article.)
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Fig. 4. Reproducibility of H7N9 RT-RPA assays. (A) H7 and (B) N9 RT-RPA assays.
Semilogarithmic regression of the data collected from eight H7N9 RT-RPA test runs
on  the RNA molecular standard using Prism Software. Both assays yielded results
between 2 and 7 min. In the H7 RT-RPA assay, 107–102 RNA molecules were detected
in  eight out of eight, and 10 in six of eight RT-RPA runs. In the N9 assay, 107–103
RNA molecules were detected in all RT-RPA runs, 102 in seven out of eight, and 10
in  two  out of eight.A. Abd El Wahed et al. / Journal
echnologies, Darmstadt, Germany) according to the manufac-
urer’s instructions with few modiﬁcations. In summary, 200 l of
he sample was incubated with 50 l of proteinase K and 300 l
f lysis buffer for 5 min  at room temperature. Thereafter, 150 l
f isopropanol and 50 l of Dynabeads were added and incubated
or 10 min  followed by two washing steps. Nucleic acid bound to
he Dynabeads was left to dry for 5 min, followed by elution. The
otal time needed for the extraction was 30 min. For the RT-RPA
ssay, the ready-to-use TwistAmpTM RT exo (TwistDx, Cambridge,
K) was used as described [11]. Brieﬂy, RPA primers (420 nM), the
robe (120 nM), 45 l of rehydration buffer containing 14 mM Mg
cetate, and 5 l of extracted RNA were added. The tube was  closed
nd mixed well, and then placed in the tube scanner for 10 min  at
2 ◦C. The total time for the RT-RPA test was 15 min. All pipetting
teps were performed in the suitcase area. Surfaces outside of the
uitcase were not used.
.4. Analytical sensitivity and speciﬁcity of H7N9 RT-RPA assays
In vitro transcribed HA and NA RNAs of the H7N9
/Anhui/1/2013 virus (accession numbers: EPI439507, EPI439509)
ere provided by the Friedrich-Loefﬂer-Institute, Greifswald-Insel
iems, Germany [15]. To determine the analytical sensitivity of
T-RPA assays, RNA molecular standard quantities ranging from
07 to 101 RNA molecules/l were used. The RT-RPA assay was
erformed using the ready-to-use TwistAmpTM RT exo (TwistDx,
ambridge, UK) as described before [15]. Using PRISM (Graphpad
oftware Inc., San Diego, CA, USA), the threshold time was  plotted
gainst molecules detected and a semilog regression was  calcu-
ated. To determine the limit of detection at 95% probability, a
robit regression was performed using STATISTICA (StatSoft, Ham-
urg, Germany). The speciﬁcity of RT-RPA assays was  determined
y testing six H7N9-negative chicken samples and a reference
uman genome. In addition, the cross-reactivity was tested using
he viral nucleic acids listed in Table 1. For comparison, H7N9
eal-time RT-PCR was performed as previously described [16].
. Results
Two RT-RPA assays were designed for the detection of avian
nﬂuenza A (H7N9) virus. Two molecular in vitro transcribed RNA
tandards (H7 and N9) were implemented to evaluate both RT-RPA
ssays. A dilution range of 107–101 molecules/l of the RNA H7 and
9 molecular standards was used to select the RT-RPA primer and
robe combination to produce the highest assay analytical sensi-
ivity. RPA primers and exo-Ps listed in Table 2 yielded an analytical
ensitivity between 10 and 100 RNA molecules for the H7 and N9
T-RPA assays, respectively (Fig. 3).
Using the data of eight RT-RPA runs of RNA molecular standard
erial dilutions, a semilog regression (Fig. 4) and probit regression
nalysis (Fig. 5) were carried out. The run times for both assays were
etween 2 and 7 min  (Fig. 4). The limits of detection in 95% of cases
ere calculated to be 14 (Fig. 5A) and 179 (Fig. 5B) RNA molecules
etected for the H7 and the N9 RT-RPA assays, respectively. Both
he H7 and N9 RT-RPA assays were speciﬁc. They detected neither
iral nucleic acids of other respiratory viruses (Table 1) nor the
uman or the avian genome. Unfortunately, no clinical samples
ere available to test the clinical sensitivity of the assay.
. DiscussionThe avian inﬂuenza A (H7N9) virus, which mainly infects birds,
lso occasionally infects humans [17]. As of 22 December 2013, 71
eaths of 166 laboratory-conﬁrmed human cases were recorded by
he World Health Organization (WHO) in restricted parts of China
Fig. 5. Probit analysis of H7N9 RT-RPA assays. (A) H7 and (B) N9 RT-RPA assays.
Probit regression analysis using STATISTICA software on the data set of the eight RT-
RPA assay runs. The limit of detection at 95% probability (14 and 179 RNA molecules
for the H7 and N9 RT-RPA assays, respectively) is represented by a triangle.
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ncluding Hong Kong. By 14 November 2014, the number of con-
rmed human cases increased to 458, 177 of which were fatalities.
n addition, infected cases were reported in Taiwan and Malaysia
18], suggesting the spread of the virus to other countries as well.
hus, it is absolutely necessary to detect an H7N9 outbreak as early
s possible to initiate appropriate control measures and prevent
urther spread among birds or transmission to humans.
Several real-time RT-PCRs were developed for sensitive detec-
ion of avian inﬂuenza (H7N9) virus [15,16,19]. They produced
esults in 50–90 min. To avoid contamination of reagents or the
orkplace with PCR amplicons, the preparation of the master mix,
ddition of the sample RNA to the mix, and the PCR reaction must be
erformed in separate biological safety cabinets or pipetting hoods.
oreover, real-time RT-PCR reagents must be stored in a freezer at
20 ◦C. Therefore, real-time RT-PCR is not easy to use at the point
f need or in the ﬁeld.
The detection of avian inﬂuenza (H7N9) virus was also
erformed by reverse transcription-loop-mediated isothermal
mpliﬁcation (RT-LAMP) [20–24]. RT-LAMP ampliﬁcation was
chieved at 60 ◦C in >30 min, and readout was done with the naked
ye or SYBR Green-based detection. However, RT-LAMP needs six
o 12 primers for the ampliﬁcation of the H7 and N9 genes, which
re not easy to design especially for highly variable RNA viruses.
y contrast, the H7N9 RT-RPA assays developed in this study were
ery fast (2–7 min). They were operated at a single temperature
42 ◦C), and only four primers and two exo-Ps were needed for the
mpliﬁcation and detection of two genes (H7 and N9). Moreover,
he analytical sensitivity and speciﬁcity of the RT-RPA assays were
s good as that of the published real-time-RT-PCR [16].
To allow for the use of the RT-RPA assay at quarantine sta-
ions, ports, or the site of outbreak, the developed DiaS contains
he complete equipment and reagents needed to perform on-site
PA-based diagnostic test. DiaS has the same size as a standard
uitcase, which is easy to carry, transport, and ship. The DiaS cur-
ently costs around 5000 euro. The system can be used with a solar
anel and/or power pack as a source of energy for easy use in low-
esource settings. All RT-RPA reagents and oligonucleotides can be
tored at ambient temperature for up to 3 months. RNA extrac-
ion is achieved by a magnetic-bead-based method, which reduces
he risk of environmental contamination because no centrifugation
tep is needed. Six samples can be tested at the same time, in addi-
ion to negative and positive controls. Kits for up to 98 samples can
e stored in the DiaS. The DiaS storage box can be reﬁlled when-
ver needed. Results are displayed as positive or negative on the
creen of the tube scanner without the need of a laptop. Overall,
ine pipetting steps are needed. Further improvements to reduce
he pipetting steps could be to include lyophilized RPA primers and
robe into the RPA pellet, to employ a multiplex RT-RPA assay, and
o apply simple non-puriﬁcation lysis. In addition, generic inﬂuenza
T-RPA assays for detection of inﬂuenza type A and B as well as
5N1 are being developed, but they have not yet been included
25].
In conclusion, the developed DiaS represents a portable, rapid,
nd simple platform for the detection of avian inﬂuenza A (H7N9)
irus at the point of need and in low-resource settings. DiaS
epends on the RPA technique for identifying the RNA of the H7N9
irus, which can be optimized for the detection of the genome of
ther infectious agents as well.
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